Seema Bansal

Seema Bansal, Ph.D. is a Technical Director at Bristol Myers Squibb, specializing in vector analytical strategy for LVV-based CAR-T cell therapies. She leads end-to-end vector control strategy across clinical and commercial programs, including supporting life cycle management for ABECMA® and BREYANZI®. With deep expertise in regulatory submissions, potency methods, and specifications, she drives science-based analytical frameworks to deliver innovative cell and gene therapies to patients.